JDR Vol.19 No.3 pp. 580-589
doi: 10.20965/jdr.2024.p0580


Social Support Is Associated with Fewer Mental Health Problems Among Japanese Nurses During COVID-19 Pandemic: A Cross-Sectional Study

Michihiro Tsubaki*1,† ORCID Icon, Yoshiyasu Ito*2 ORCID Icon, Takafumi Nagashima*3 ORCID Icon, Yoko Tsujimoto*4, Toru Anzai*4, Susumu Yagome*5 ORCID Icon, and Hideko Koizumi*6

*1School of Nursing, Kitasato University
1-15-1 Kitazato, Minami-ku, Sagamihara, Kanagawa 252-0373, Japan

Corresponding author

*2College of Nursing Art and Science, University of Hyogo
Akashi, Japan

*3Sagamihara Nursing Vocational School
Sagamihara, Japan

*4Emergency and Critical Care Center, Tokai University Hospital
Isehara, Japan

*5Graduate School of Data Science, Yokohama City University
Yokohama, Japan

*6Department of Youth, Kanagawa Nursing Federation
Yokohama, Japan

November 10, 2023
March 4, 2024
June 1, 2024
anxiety, depression, occupational mental health, political issues, post-traumatic stress disorder

This study aims to assess the relationship between the effect of the pandemic on the mental health of nurses and its association with their social support needs. Infectious disease pandemics have had a considerable impact on the medical healthcare industry and the global economy, and the construction of a sustainable medical system is essential for overcoming them. This cross-sectional study evaluated 2431 Japanese nurses who completed a survey using three mental health scales for depression, anxiety, and post-traumatic stress. It was found that the odds of depression were lower among nurses who received sufficient infection prevention measures than those who felt that no preventive measures were implemented. Nurses who sought financial support and support against libel and slander were associated with a high risk of depression. These items were associated with a high risk of anxiety disorder and post-traumatic stress disorder. The increased mental health problems among nurses require evidence-based social support, including countermeasures against infection in hospital, financial support for individual nurses, and support against libel and slander to improve their mental health.

Cite this article as:
M. Tsubaki, Y. Ito, T. Nagashima, Y. Tsujimoto, T. Anzai, S. Yagome, and H. Koizumi, “Social Support Is Associated with Fewer Mental Health Problems Among Japanese Nurses During COVID-19 Pandemic: A Cross-Sectional Study,” J. Disaster Res., Vol.19 No.3, pp. 580-589, 2024.
Data files:
  1. [1] Ministry of Health, Labour and Welfare, “Novel coronavirus (COVID-19)” (in Japanese). [Accessed November 12, 2020]
  2. [2] Y. Fujii and K. Hirota, “Critical care demand and intensive care supply for patients in Japan with COVID-19 at the time of the state of emergency declaration in April 2020: A descriptive analysis,” Medicina, Vol.56, No.10, Article No.530, 2020.
  3. [3] M. Nicola et al., “The socio-economic implications of the coronavirus pandemic (COVID-19): A review,” Int. J. Surg., Vol.78, pp. 185-193, 2020.
  4. [4] E. M. Rees et al., “COVID-19 length of hospital stay: A systematic review and data synthesis,” BMC Med., Vol.18, No.1, Article No.270, 2020.
  5. [5] M. Nakamura and M. Hitosugi, “Emerging COVID-19-related deaths during home recuperation in Japan,” Geriatr. Gerontol. Int., Vol.21, No.5, pp. 436-437, 2021.
  6. [6] G. H.-H. Jen et al., “Evaluating medical capacity for hospitalization and intensive care unit of COVID-19: A queue model approach,” J. Formos. Med. Assoc., Vol.120, Supplement 1, pp. S86-S94, 2021.
  7. [7] J. Phua et al., “Intensive care management of coronavirus disease 2019 (COVID-19): Challenges and recommendations,” Lancet Respir. Med., Vol.8, No.5, pp. 506-517, 2020.
  8. [8] T. Yamamoto et al., “Assessment of critical care surge capacity during the COVID-19 pandemic in Japan,” Health Secur., Vol.19, No.5, pp. 479-487, 2021.
  9. [9] L. J. Labrague and J. A. A. de Los Santos, “Fear of COVID-19, psychological distress, work satisfaction and turnover intention among frontline nurses,” J. Nurs. Manag., Vol.29, No.3, pp. 395-403, 2021.
  10. [10] R. M. Said and D. A. El-Shafei, “Occupational stress, job satisfaction, and intent to leave: Nurses working on front lines during COVID-19 pandemic in Zagazig City, Egypt,” Environ. Sci. Pollut. Res., Vol.28, No.7, pp. 8791-8801, 2021.
  11. [11] Japanese Nursing Association, “Survey on the response to new coronavirus infections by nursing staff” (in Japanese). [Accessed November 12, 2021]
  12. [12] Y. Kuramoto, “Influence that the experience after the East Japan Great Earthquake disaster gave in change quitting a job of physician and nurse – Knowledge to the disaster retention management of the hospital organization,” J. Jpn. Assoc. Health Care Adm., Vol.9, No.1, pp. 13-19, 2015 (in Japanese).
  13. [13] J. H. De Kock et al., “A rapid review of the impact of COVID-19 on the mental health of healthcare workers: Implications for supporting psychological well-being,” BMC Public Health, Vol.21, No.1, Article No.104, 2021.
  14. [14] M. M. Hossain et al., “Epidemiology of mental health problems in COVID-19: A review,” F1000Research, Vol.9, Article No.636, 2020.
  15. [15] W. Wang et al., “Sleep disturbance and psychological profiles of medical staff and non-medical staff during the early outbreak of COVID-19 in Hubei Province, China,” Front. Psychiatry, Vol.11, Article No.733, 2020.
  16. [16] J. M. Cénat et al., “Prevalence of symptoms of depression, anxiety, insomnia, posttraumatic stress disorder, and psychological distress among populations affected by the COVID-19 pandemic: A systematic review and meta-analysis,” Psychiatry Res., Vol.295, Article No.e113599, 2021.
  17. [17] L. Xing et al., “Anxiety and depression in frontline health care workers during the outbreak of Covid-19,” Int. J. Soc. Psychiatry, Vol.67, No.6, pp. 656-663, 2021.
  18. [18] N. Awano et al., “Anxiety, depression, and resilience of healthcare workers in Japan during the coronavirus disease 2019 outbreak,” Intern. Med., Vol.59, No.21, pp. 2693-2699, 2020.
  19. [19] S. G. Toh, E. Ang, and M. K. Devi, “Systematic review on the relationship between the nursing shortage and job satisfaction, stress and burnout levels among nurses in oncology/haematology settings,” Int. J. Evid.-Based Healthc., Vol.10, No.2, pp. 126-141, 2012.
  20. [20] J. Lai et al., “Factors associated with mental health outcomes among health care workers exposed to coronavirus disease 2019,” JAMA Netw. Open, Vol.3, No.3, Article No.e203976, 2020.
  21. [21] M. Vizheh et al., “The mental health of healthcare workers in the COVID-19 pandemic: A systematic review,” J. Diabetes. Metab. Disord., Vol.19, No.2, pp. 1967-1978, 2020.
  22. [22] P. Peduzzi et al., “A simulation study of the number of events per variable in logistic regression analysis,” J. Clin. Epidemiol., Vol.49, No.12, pp. 1373-1379, 1996.
  23. [23] K. Kroenke, R. L. Spitzer, and J. B. W. Williams, “The PHQ-9: Validity of a brief depression severity measure,” J. Gen. Intern. Med., Vol.16, No.9, pp. 606-613, 2001.
  24. [24] L. Bao, W.-T. Li, and B.-L. Zhong, “Feelings of loneliness and mental health needs and services utilization among Chinese residents during the COVID-19 epidemic,” Glob. Health, Vol.17, No.1, Article No.51, 2021.
  25. [25] B. Löwe et al., “measuring depression outcome with a brief self-report instrument: Sensitivity to change of the patient health questionnaire (PHQ-9),” J. Affect. Disord., Vol.81, No.1, pp. 61-66, 2004.
  26. [26] R. L. Spitzer et al., “Validation and utility of a self-report version of PRIME-MD: The PHQ primary care study,” JAMA, Vol.282, No.18, pp. 1737-1744, 1999.
  27. [27] B. Levis et al., “Selective cutoff reporting in studies of diagnostic test accuracy: A comparison of conventional and individual-patient-data meta-analyses of the patient health questionnaire-9 depression screening tool,” Am. J. Epidemiol., Vol.185, No.10, pp. 954-964, 2017.
  28. [28] K. Muramatsu et al., “Performance of the Japanese version of the patient health questionnaire-9 (J-PHQ-9) for depression in primary care,” Gen. Hosp. Psychiatry, Vol.52, pp. 64-69, 2018.
  29. [29] R. L. Spitzer et al., “A brief measure for assessing generalized anxiety disorder: The GAD-7,” Arch. Intern. Med., Vol.166, No.10, pp. 1092-1097, 2006.
  30. [30] E. J. Kyzar et al., “Anxiety, depression, insomnia, and trauma-related symptoms following COVID-19 infection at long-term follow-up,” Brain Behav. Immun. Health., Vol.16, Article No.100315, 2021.
  31. [31] K. Muramatsu et al., “Validation and utility of a Japanese version of the GAD-7,” Japanese J. of Psychosomatic Medicine, Vol.50, No.6, p. 592, 2010 (in Japanese).
  32. [32] R. Gargurevich et al., “Factor structure of the Impact of Event Scale-Revised in two different Peruvian samples,” Depress. Anxiety, Vol.26, No.8, pp. E91-E98, 2009.
  33. [33] J. Bohlken et al., “COVID-19 pandemic: Stress experience of healthcare workers: A short current review,” Psychiatr. Prax., Vol.47, No.4, pp. 190-197, 2020 (in German).
  34. [34] Kanagawa Prefectural Government, “Outbreaks of patients infected with the new coronavirus” (in Japanese). [Accessed November 8, 2021]
  35. [35] S. A. Gómez-Ochoa et al., “COVID-19 in health-care workers: A living systematic review and meta-analysis of prevalence, risk factors, clinical characteristics, and outcomes,” Am. J. Epidemiol., Vol.190, No.1, pp. 161-175, 2021.
  36. [36] Ministry of Health, Labour and Welfare, “Project for granting consolation money to those engaged in responding to new coronavirus infections” (in Japanese). [Accessed November 12, 2020]
  37. [37] H. Lei et al., “Household transmission of COVID-19—A systematic review and meta-analysis,” J. Infect., Vol.81, No.6, pp. 979-997, 2020.
  38. [38] Z. J. Madewell et al., “Household transmission of SARS-CoV-2: A systematic review and meta-analysis,” JAMA Netw. Open, Vol.3, No.12, Article No.e2031756, 2020.
  39. [39] N. Barda et al., “Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: An observational study,” Lancet, Vol.398, No.10316, pp. 2093-2100, 2021.
  40. [40] Y. Goldberg et al., “Waning immunity after the BNT162b2 vaccine in Israel,” N. Engl. J. Med., Vol.385, No.24, Article No.e85, 2021.
  41. [41] M. Y. Sorokin et al., “Stress and stigmatization in health-care workers during the COVID-19 pandemic,” Indian J. Psychiatry, Vol.62, No.Suppl.3, pp. S445-S453, 2020.
  42. [42] B. Charles et al., “Association between stigma, depression and quality of life of people living with HIV/AIDS (PLHA) in South India—A community based cross sectional study,” BMC Public Health, Vol.12, No.1, Article No.463, 2012.
  43. [43] Y. Yuan et al., “COVID-19-related stigma and its sociodemographic correlates: A comparative study,” Global. Health, Vol.17, No.1, Article No.54, 2021.

*This site is desgined based on HTML5 and CSS3 for modern browsers, e.g. Chrome, Firefox, Safari, Edge, Opera.

Last updated on Jun. 03, 2024